Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Biomaterial
81%
Disease
72%
Nanoparticle
66%
Biomaterial
54%
Clinical Trial
54%
Quercetin
54%
Nanocomposite
54%
Hydroxyapatite
54%
Autoimmune Disease
54%
Diabetes Mellitus
54%
Nanoemulsion
54%
Povidone
54%
Agarose
54%
Alginic Acid
54%
Tissue Adhesion
54%
Cardiovascular Disease
54%
Therapeutic Use
36%
Immunotherapy
36%
Pharmaceutics
27%
Tissue Repair
27%
Heart Infarction
27%
Biological Half-Life
6%
Cytotoxicity
6%
Nanocarrier
6%
Drug Release
6%
Sustained Release
6%
Zeta Potential
6%
Keyphrases
Immunotherapeutic Nanoparticles
54%
Cell-based
54%
Alginate Hydrogel
54%
Diabetes Management
54%
Double Nanoemulsion
54%
Cell-laden Hydrogel
54%
Stem Cells
27%
Technological Perspective
27%
Insulin Injection
27%
Diabetes
27%
Cell Encapsulation
27%
Technological Challenges
27%
Cellular Device
27%
Clinical Progress
27%
Insulin
27%
Biomaterials
27%
Medical Conditions
27%
Expert Opinion
27%
Biological Perspective
27%
Area Cover
27%
Type 1 Diabetes Mellitus (T1DM)
27%
Clinical Trials
27%
Immune Rejection
10%
Non-stem Cells
10%
Cardiovascular Healthcare
10%
Proliferation Phase
10%
Healable
10%
Scar Tissue Formation
10%
Tissue Adhesions
9%
Closing Process
9%
Self-healing Adhesive
9%
Oil-in-water Nanoemulsion
6%
Korsmeyer-Peppas
6%
FESEM Images
6%